SanofiSNY.OValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, Sanofi (SNY.O) trades at a P/E of 21.80x, P/B of 1.25x, P/S of 1.77x, and a dividend yield of 4.92%.
Longitudinal percentile comparison: P/E sits at the 70th percentile over the trailing 10Y window (vs. 59th percentile over 3Y); P/B sits at the 1st percentile over the trailing 10Y window (vs. 3rd percentile over 3Y); P/S sits at the 1st percentile over the trailing 10Y window (vs. 2nd percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 44th percentile within its industry and the 56th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 10.91%, ranking at the 100th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 68.6 points apart — worth checking the full percentile matrix on this page for the complete picture. The P/E percentile sits lower within its industry than across the market as a whole — relatively cheaper next to direct peers. Of the 10.91% total shareholder yield, 4.92% is paid out as dividends and roughly 5.99% is implied to come from buybacks — both channels are meaningfully in play. Sanofi operates in the Manufacturing sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NASDAQ: SNY · SNY
Want the full picture on whether Sanofi (SNY.O) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 21.80 | ||||||
| P/B (MRQ) | 1.25 | ||||||
| P/S (TTM) | 1.77 | ||||||
| Dividend Yield | 4.92% | ||||||
| Buyback + Div Yield | 10.91% |